Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Lee’s Pharmaceutical Holdings Limited ( (HK:0950) ) is now available.
Lee’s Pharmaceutical Holdings Limited has announced a board meeting scheduled for March 27, 2025, to discuss the approval of the company’s annual results for the year ending December 31, 2024, and to consider recommending a final dividend. This meeting is significant for stakeholders as it will provide insights into the company’s financial performance and potential returns for investors.
More about Lee’s Pharmaceutical Holdings Limited
Lee’s Pharmaceutical Holdings Limited is a company incorporated in the Cayman Islands, primarily operating in the pharmaceutical industry. It focuses on developing, manufacturing, and marketing pharmaceutical products, with a market presence in Hong Kong.
YTD Price Performance: -10.56%
Average Trading Volume: 192,532
Technical Sentiment Consensus Rating: Hold
Current Market Cap: HK$747.8M
For detailed information about 0950 stock, go to TipRanks’ Stock Analysis page.